CoChat

Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women.

Wilkinson, David, Tholandi, Maya, Ramjee, Gita, Rutherford, George W · 2002 · The Lancet Infectious Diseases

The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.

Abstract

We aimed to determine the effectiveness of the vaginally administered spermicide nonoxynol-9 (N-9) among women for the prevention of HIV and other sexually transmitted infections (STIs). We did a systematic review of randomised controlled trials. Nine such trials including 5096 women, predominantly sex workers, comparing N-9 with placebo or no treatment, were included. Primary outcomes were new HIV infection, new episodes of various STIs, and genital lesions. Five trials included HIV and nine included STI outcomes, and all but one (2% of the data) contributed to the meta-analysis. Overall, relative risks of HIV infection (1.12, 95% confidence interval 0.88-1.42), gonorrhoea (0.91, 0.67-1.24), chlamydia (0.88, 0.77-1.01), cervical infection (1.01, 0.84-1.22), trichomoniasis (0.84, 0.69-1.02), bacterial vaginosis (0.88, 0.74-1.04) and candidiasis (0.97, 0.84-1.12) were not significantly different in the N-9 and placebo or no treatment groups. Genital lesions were more common in the N-9 group (1.18, 1.02-1.36). Our review has found no statistically significant reduction in risk of HIV and STIs, and the confidence intervals indicate that any protection that may exist is likely to be very small. There is some evidence of harm through genital lesions. N-9 cannot be recommended for HIV and STI prevention.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(02)00396-1

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 23 references

Research works printed but not linked: 2

  1. Cutler, 1977, Vaginal contraceptives as prophylaxis against gonorrhoea and other sexually transmissible diseases, Adv Planned Parenthood, 12, 45
  2. Rendon, 1980, A controlled comparative study of phenylmercuric acetate, nonoxynol-9 and placebo vaginal suppositories as prophylactic agents against gonorrhoea, Current Therapeutic Research, 27, 780

Cited by

See all 107

Metadata

Authors
Wilkinson, D., Tholandi, M., Ramjee, G., & Rutherford, G. W.
Affiliations
  • University of South Australia (AU)
  • University of California, San Francisco (US)
Corresponding author
Wilkinson, David
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2002-10
Volume
2
Issue
10
Pages
613-617
ISSN
1473-3099 (ISSN-L)
OpenAlex
W2139075759
Cited by
107
References
24
Citations by year
2025: 5 · 2023: 3 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 6 · 2016: 5 · 2015: 3 · 2014: 7 · 2013: 2 · 2012: 4
FWCI
1.38
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The Lancet Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Keywords
nonoxynol-9, spermicides, HIV prevention, sexually transmitted infections, sex workers, gonorrhea, chlamydia, trichomoniasis, bacterial vaginosis, candidiasis, genital lesions
MeSH terms
Adult, Anti-Infective Agents, Female, Humans, Sexually Transmitted Diseases, Spermatocidal Agents, HIV Infections, Randomized Controlled Trials as Topic, Nonoxynol

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women. https://app.cochat.ai/papers/10.1016/s1473-3099(02)00396-1
The paper
Wilkinson, D., Tholandi, M., Ramjee, G., & Rutherford, G. W. (2002). Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(02)00396-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.